Strategy and Commercial Infrastructure Needed to Scale Medtech in the U.S. | LSI Asia '25

This Panel took place at LSI Asia ‘25 Emerging Medtech Summit in Singapore.This panel examines the strategies and commercial infrastructure necessary for successfully scaling medtech companies in the U.S., featuring perspectives from industry leaders.This Panel featured:Fredrik Nyberg — Managing Director Asia Pacific, Medtech InnovatorWeronika Michaluk — MedTech Practice Lead, HTD HealthKenneth Nelson — Angel Investor & Partner, MedTech Advantage FundDavid Uffer — Managing Director, MedTech, Trinity LifesciencesJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.